Ergo Science Corp
OTC:ERGN
Balance Sheet
Balance Sheet Decomposition
Ergo Science Corp
Current Assets | 10.9m |
Cash & Short-Term Investments | 3.5m |
Other Current Assets | 7.4m |
Non-Current Assets | 17.2m |
PP&E | 4.3m |
Intangibles | 4.3m |
Other Non-Current Assets | 8.5m |
Current Liabilities | 10.8m |
Other Current Liabilities | 10.8m |
Balance Sheet
Ergo Science Corp
Dec-1997 | Dec-1998 | Dec-1999 | Dec-2000 | Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
14
|
16
|
4
|
10
|
26
|
25
|
27
|
2
|
7
|
5
|
|
Cash Equivalents |
14
|
16
|
4
|
10
|
26
|
25
|
27
|
2
|
7
|
5
|
|
Short-Term Investments |
10
|
18
|
18
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
5
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
5
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
5
|
|
Total Current Assets |
24
|
34
|
22
|
27
|
26
|
25
|
27
|
11
|
14
|
9
|
|
PP&E Net |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
|
PP&E Gross |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
|
Accumulated Depreciation |
4
|
6
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
5
|
|
Long-Term Investments |
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
8
|
8
|
|
Total Assets |
29
N/A
|
35
+21%
|
30
-12%
|
27
-11%
|
26
-5%
|
25
-3%
|
27
+8%
|
90
+232%
|
32
-64%
|
26
-18%
|
|
Liabilities | |||||||||||
Accounts Payable |
3
|
4
|
5
|
1
|
0
|
0
|
0
|
4
|
2
|
0
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
4
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
5
|
8
|
|
Total Current Liabilities |
3
|
5
|
5
|
1
|
1
|
1
|
0
|
14
|
11
|
8
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
32
|
0
|
0
|
|
Total Liabilities |
4
N/A
|
5
+39%
|
5
-6%
|
1
-79%
|
1
-5%
|
1
-26%
|
0
-47%
|
46
+12 523%
|
11
-77%
|
8
-24%
|
|
Equity | |||||||||||
Common Stock |
5
|
6
|
6
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
78
|
84
|
88
|
88
|
89
|
90
|
85
|
0
|
88
|
94
|
|
Additional Paid In Capital |
101
|
112
|
112
|
112
|
112
|
112
|
112
|
0
|
112
|
112
|
|
Other Equity |
4
|
4
|
4
|
5
|
2
|
2
|
2
|
43
|
4
|
2
|
|
Total Equity |
25
N/A
|
30
+19%
|
26
-14%
|
26
+1%
|
25
-5%
|
24
-2%
|
27
+10%
|
43
+63%
|
21
-51%
|
18
-15%
|
|
Total Liabilities & Equity |
29
N/A
|
35
+21%
|
30
-12%
|
27
-11%
|
26
-5%
|
25
-3%
|
27
+8%
|
90
+232%
|
32
-64%
|
26
-18%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|